Head & Neck/Thyroid Cancers
Feature
Can an app guide cancer treatment decisions during the pandemic?
Feature
‘A good and peaceful death’: Cancer hospice during the pandemic
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
News
Oncologists’ income and satisfaction are up
From the Journals
World first: Saliva test detects occult HPV-driven oropharyngeal cancer
Conference Coverage
Video coaching may relieve anxiety and distress for long-distance cancer caregivers
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital
News from the FDA/CDC
FDA approves selpercatinib for lung and thyroid RET tumors
From the Journals
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
From the Journals
Excess cancer deaths predicted as care is disrupted by COVID-19